Wellness Influencers Are Waging War Against Almonds. Could the Nut Really Be 'Toxic?'

But humanity has been biohacking since ancient times—and almonds, a portable nutrient bomb, were a tempting snack for Bronze ...
Medical Marketing & Media

Two new Untitled Letters, multiple close-outs: Latest on FDA’s pharma ad crackdown

More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one ...
Becker's Hospital Review

FDA panel pushes to reclassify testosterone therapy

An FDA panel pushes reclassify testosterone therapy by recommending removal of controlled substance status and expanding treatment eligibility.

Trends in Edible Oil Packaging Market 2025-2035

According to projections from Towards Packaging, the global edible oil packaging market is set to increase from USD 7.21 ...

Innoviva Specialty Therapeutics Announces Publication in The Lancet of Positive Zoliflodacin Phase 3 Data for the Treatment of Uncomplicated Urogenital Gonorrhea

Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced the publication of positive results from a pivotal Phase 3 trial evaluating its investigational ...